AT-Patch (ATP-C130/ATP-C70) vs cV8 Diagnostic Ultrasound System
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you require continuous, long-term cardiac rhythm monitoring for up to 14 days in an outpatient setting. This wearable device is ideal for detecting intermittent arrhythmias that may be missed during shorter monitoring periods, offering patient comfort with its compact, shower-proof design and AI-powered analysis for efficient diagnosis.
View AT-Patch (ATP-C130/ATP-C70) →Choose cV8 Diagnostic Ultrasound System if…
Choose the Samsung Medison cV8 if your clinical practice demands real-time, high-resolution diagnostic imaging across diverse specialties, including neurology, obstetrics, gynecology, and cardiology. This system is best suited for scenarios requiring superior image clarity, advanced AI-based diagnostic assistance, and streamlined workflows for immediate and detailed visualization of anatomical structures and physiological processes.
View cV8 Diagnostic Ultrasound System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | cV8 Diagnostic Ultrasound System |
|---|---|---|
| Pricing | N/a | Varies |
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | On-premise (hospital environments and outpatient diagnostic clinics) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)Tool A, AT-Patch, is designed for patient comfort and ease of use, being a compact, lightweight, shower-proof wearable that requires no charging or electrode replacement for up to 14 days. Its accompanying smartphone app further simplifies live ECG viewing and symptom recording for the patient. Tool B, while ergonomically designed for clinicians, is a complex diagnostic system requiring professional operation.
Clinical Value
cV8 Diagnostic Ultrasound SystemTool B, the cV8 Diagnostic Ultrasound System, offers superior image quality through its Crystal Architecture and a broad range of AI-based diagnostic assistance tools across multiple specialties, including neurology, obstetrics & gynecology, and radiology. This provides a wider and deeper clinical impact compared to Tool A's focused, albeit valuable, long-term cardiac monitoring with AI arrhythmia detection.
Pricing & Value
TieNeither Tool A nor Tool B provides publicly available pricing information. Both are high-value medical devices typically sold directly to medical institutions, making a direct comparison of their pricing and overall value impossible without specific vendor quotes or cost-effectiveness studies.
Enterprise Readiness
cV8 Diagnostic Ultrasound SystemTool B explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are crucial for enterprise deployment and data governance in healthcare. Tool A mentions HIPAA compliance is 'likely' but does not explicitly confirm a BAA, indicating less transparency regarding enterprise-level data security and contractual readiness.
Innovation
cV8 Diagnostic Ultrasound SystemTool B showcases a broader and deeper range of innovative features, including advanced Crystal Architecture for superior imaging and multiple specialized AI-driven diagnostic assistance tools like NerveTracku2122 and HeartAssistu2122. While Tool A innovates with its long-duration, comfortable wearable design and integrated AI for arrhythmia detection, Tool B's extensive suite of advanced imaging and AI capabilities across diverse applications demonstrates a higher degree of technological innovation.
Support & Docs
TieBoth ATsens (for AT-Patch) and Samsung Medison (for cV8) provide user manuals and support resources online. However, the available information does not offer a comparative basis to determine which company provides superior support or documentation in terms of responsiveness, comprehensiveness, or accessibility for a head-to-head comparison.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | cV8 Diagnostic Ultrasound System |
|---|---|---|
| Name | AT-Patch (ATP-C130/ATP-C70) | cV8 Diagnostic Ultrasound System |
| Description (Purpose) | FDA-cleared wearable ECG monitor offering up to 14 days of continuous cardiac monitoring with high accuracy and integrated AI-powered analysis software. | Premium, mobile, and software-controlled ultrasound system featuring advanced Crystal Architectureu2122 for superior image quality and AI-based diagnostic assistance tools. |
| Company | ATsens Co. | Samsung Medison Co. |
| Primary Function/Category | Ambulatory ECG Monitor (Cardiology AI, Wearables & Remote Monitoring) | Diagnostic Ultrasound System (Cardiology AI, Radiology & Imaging AI) |
| Key AI Features | AI/machine learning algorithms for ECG analysis (AT-Report software) | NerveTracku2122, UterineAssistu2122, BiometryAssistu2122, ViewAssistu2122, HeartAssistu2122 (AI-based Intelligent Assist solutions) |
| Target Specialties | Cardiology, Family Medicine, Internal Medicine | Neurology, Obstetrics & Gynecology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and cV8 Diagnostic Ultrasound System.